At the present study, we analyzed by CellMiner that the expression level of PFKP was positively related to the drug activity of protein kinase C (PKC) inhibitor Staurosporine (S4 Table), suggesting that the expression level of PFKP could affect the drug sensitivity of breast cancer cells to PKC inhibitors. This evidence concerns the gene PRRT2 and breast cancer.